Phase 2 Study of ALIMTA (Pemetrexed) Plus Cisplatin as First-Line Treatment of Gastric Cancer.

Trial Profile

Phase 2 Study of ALIMTA (Pemetrexed) Plus Cisplatin as First-Line Treatment of Gastric Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2015

At a glance

  • Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 18 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jun 2008 The expected completion date for this trial is now 1 May 2010 as reported by ClinicalTrials.gov.
    • 27 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top